Frederick Regional Healthcare Systems/James M. Stockman Cancer Institute is a clinical research site located in Frederick, Maryland, United States 21702.
Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.
Frederick Regional Healthcare Systems/James M. Stockman Cancer Institute has participated in 1 clinical trials.
Therapeutic areas: Advanced Cholangiocarcinoma, FGFR2 Gene Mutation.
Sponsors: QED Therapeutics, a BridgeBio company.
Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Frederick Regional Healthcare Systems/James M. Stockman Cancer Institute has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Frederick Regional Healthcare Systems/James M. Stockman Cancer Institute has 1 clinical trials on record. Their work covers Advanced Cholangiocarcinoma, FGFR2 Gene Mutation.
Frederick Regional Healthcare Systems/James M. Stockman Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.